Kudela Erik, Nachajova Marcela, Biringer Kamil, Slavik Pavol, Plank Lukas, Danko Jan
Department of Obstetrics and Gynaecology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia.
Department of Obstetrics and Gynaecology, Jessenius Faculty of Medicine in Martin, Comenius University in Bratislava, Slovakia.
Int J Surg Case Rep. 2018;42:90-93. doi: 10.1016/j.ijscr.2017.11.064. Epub 2017 Dec 7.
Ovarian teratomas undergo the malignant transformation in 0.2-2% of cases. The behavior of malignancies in mature cystic teratomas (MCT) is determined by their phenotype and not their derivation from germ cells. We can recognize pure angiosarcomas or as a part of other tumors like malignant mixed Mullerian tumors and adenosarcomas.
We present the first case of bilateral ovarian angiosarcoma arising from the mature teratomas. Due to widespread disease, we performed limited surgical procedure consisting of bilateral adnexectomy and omentectomy. Exploratory laparotomy in 44-year old patient showed massive ascites, necrotic tissue of omentum and bilateral tumors originating from both ovaries measuring 8 and 6cm with necrotic surface. Immunohistochemistry of the tumors showed positive staining for CD31, vimentin, desmin and focal positivity for CD34.
Sarcomas of gynecologic origin are extremely rare tumors. They present with unspecified symptoms and are diagnosed in late stages of the disease. The appropriate management of angiosarcomas is difficult due to the rarity of disease and late stage of the diseases. Surgical therapy should contain the hysterectomy with bilateral salpingo-oophorectomy and omentectomy. Pelvic lymphadenectomy was not performed in published cases with no effect on patient survival.
This work summarizes the current knowledge in the diagnosis and treatment of angiosarcomas arising in the mature teratomas. Promising results are expected from the trials devoted to antiangiogenic strategies in treatment of aggressive sarcomas.
卵巢畸胎瘤发生恶性转化的病例占0.2%-2%。成熟囊性畸胎瘤(MCT)中恶性肿瘤的行为取决于其表型,而非其源于生殖细胞。我们可以识别出纯血管肉瘤,或其作为其他肿瘤的一部分,如恶性混合苗勒管肿瘤和腺肉瘤。
我们报告首例起源于成熟畸胎瘤的双侧卵巢血管肉瘤病例。由于疾病广泛扩散,我们实施了包括双侧附件切除术和大网膜切除术在内的有限手术。一名44岁患者的剖腹探查显示大量腹水、大网膜坏死组织以及双侧源自卵巢的肿瘤,大小分别为8厘米和6厘米,表面坏死。肿瘤的免疫组化显示CD31、波形蛋白、结蛋白呈阳性染色,CD34呈局灶性阳性。
妇科起源的肉瘤是极其罕见的肿瘤。它们表现出非特异性症状,在疾病晚期才被诊断出来。由于疾病罕见且处于晚期,血管肉瘤的恰当治疗很困难。手术治疗应包括子宫切除术、双侧输卵管卵巢切除术和大网膜切除术。在已发表的病例中未进行盆腔淋巴结清扫术,对患者生存率无影响。
本研究总结了成熟畸胎瘤中发生的血管肉瘤的诊断和治疗方面的现有知识。致力于抗血管生成策略治疗侵袭性肉瘤的试验有望取得良好结果。